A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.

Introduction Increased expression of IL-33 and its receptor ST2, encoded by the IL1RL1 gene, has been detected in the inflamed arteries of giant cell arteritis (GCA) patients. The aim of the present study was to investigate for the first time the potential influence of the IL33 and IL1RL1 loci on GC...

Descripción completa

Detalles Bibliográficos
Autores: Márquez, Ana, Solans, Roser, Hernández Rodríguez, José, Cid Xutglà, M. Cinta, Castañeda, Santos, Ramentol, Marc, Rodríguez-Rodríguez, Luis, Narváez García, Francisco Javier, Blanco, Ricardo, Ortego Centeno, Norberto, Palm, Oyvind, Diamantopoulos, Andreas P., Braun, Niko, Moosig, Frank, Witte, Torsten, Beretta, Lorenzo, Lunardi, Claudio, Cimmino, Marco A., Vaglio, Augusto, Salvarani, Carlo, González-Gay, Miguel A., Martín, Javier
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2014
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/118222
Acceso en línea:https://hdl.handle.net/2445/118222
Access Level:acceso abierto
Palabra clave:Arteritis de cèl·lules gegants
Interleucines
Genètica mèdica
Giant cell arteritis
Interleukins
Medical genetics
id ES_59385bcdca2afd08d11c0dceb4bf2da0
oai_identifier_str oai:diposit.ub.edu:2445/118222
network_acronym_str ES
network_name_str España
repository_id_str
spelling A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.Márquez, AnaSolans, RoserHernández Rodríguez, JoséCid Xutglà, M. CintaCastañeda, SantosRamentol, MarcRodríguez-Rodríguez, LuisNarváez García, Francisco JavierBlanco, RicardoOrtego Centeno, NorbertoPalm, OyvindDiamantopoulos, Andreas P.Braun, NikoMoosig, FrankWitte, TorstenBeretta, LorenzoLunardi, ClaudioCimmino, Marco A.Vaglio, AugustoSalvarani, CarloGonzález-Gay, Miguel A.Martín, JavierArteritis de cèl·lules gegantsInterleucinesGenètica mèdicaGiant cell arteritisInterleukinsMedical geneticsIntroduction Increased expression of IL-33 and its receptor ST2, encoded by the IL1RL1 gene, has been detected in the inflamed arteries of giant cell arteritis (GCA) patients. The aim of the present study was to investigate for the first time the potential influence of the IL33 and IL1RL1 loci on GCA predisposition. Methods A total of 1,363 biopsy-proven GCA patients and 3,908 healthy controls from four European cohorts (Spain, Italy, Germany and Norway) were combined in a meta-analysis. Six genetic variants: rs3939286, rs7025417 and rs7044343, within the IL33 gene, and rs2058660, rs2310173 and rs13015714, within the IL1RL1 gene, previously associated with immune-related diseases, were genotyped using predesigned TaqMan assays. Results A consistent association between the rs7025417 polymorphism and GCA was evident in the overall meta-analysis, under both allele (PMH = 0.041, OR = 0.88, CI 95% 0.78-0.99) and recessive (PMH = 3.40E-03, OR = 0.53, CI 95% 0.35-0.80) models. No statistically significant differences between allele or genotype frequencies for the other IL33 and IL1RL1 genetic variants were detected in this pooled analysis. Conclusions Our results clearly evidenced the implication of the IL33 rs7025417 polymorphism in the genetic network underlying GCA.Public Library of Science (PLoS)2014info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/118222Articles publicats en revistes (Medicina)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0113476PLoS One, 2014, vol. 9, num. 11, p. e113476https://doi.org/10.1371/journal.pone.0113476cc-by (c) Márquez, Ana et al., 2014http://creativecommons.org/licenses/by/3.0/esinfo:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1182222026-05-27T06:46:51Z
dc.title.none.fl_str_mv A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
title A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
spellingShingle A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
Márquez, Ana
Arteritis de cèl·lules gegants
Interleucines
Genètica mèdica
Giant cell arteritis
Interleukins
Medical genetics
title_short A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
title_full A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
title_fullStr A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
title_full_unstemmed A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
title_sort A Candidate Gene Approach Identifies an IL33 Genetic Variant as a Novel Genetic Risk Factor for GCA.
dc.creator.none.fl_str_mv Márquez, Ana
Solans, Roser
Hernández Rodríguez, José
Cid Xutglà, M. Cinta
Castañeda, Santos
Ramentol, Marc
Rodríguez-Rodríguez, Luis
Narváez García, Francisco Javier
Blanco, Ricardo
Ortego Centeno, Norberto
Palm, Oyvind
Diamantopoulos, Andreas P.
Braun, Niko
Moosig, Frank
Witte, Torsten
Beretta, Lorenzo
Lunardi, Claudio
Cimmino, Marco A.
Vaglio, Augusto
Salvarani, Carlo
González-Gay, Miguel A.
Martín, Javier
author Márquez, Ana
author_facet Márquez, Ana
Solans, Roser
Hernández Rodríguez, José
Cid Xutglà, M. Cinta
Castañeda, Santos
Ramentol, Marc
Rodríguez-Rodríguez, Luis
Narváez García, Francisco Javier
Blanco, Ricardo
Ortego Centeno, Norberto
Palm, Oyvind
Diamantopoulos, Andreas P.
Braun, Niko
Moosig, Frank
Witte, Torsten
Beretta, Lorenzo
Lunardi, Claudio
Cimmino, Marco A.
Vaglio, Augusto
Salvarani, Carlo
González-Gay, Miguel A.
Martín, Javier
author_role author
author2 Solans, Roser
Hernández Rodríguez, José
Cid Xutglà, M. Cinta
Castañeda, Santos
Ramentol, Marc
Rodríguez-Rodríguez, Luis
Narváez García, Francisco Javier
Blanco, Ricardo
Ortego Centeno, Norberto
Palm, Oyvind
Diamantopoulos, Andreas P.
Braun, Niko
Moosig, Frank
Witte, Torsten
Beretta, Lorenzo
Lunardi, Claudio
Cimmino, Marco A.
Vaglio, Augusto
Salvarani, Carlo
González-Gay, Miguel A.
Martín, Javier
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Arteritis de cèl·lules gegants
Interleucines
Genètica mèdica
Giant cell arteritis
Interleukins
Medical genetics
topic Arteritis de cèl·lules gegants
Interleucines
Genètica mèdica
Giant cell arteritis
Interleukins
Medical genetics
description Introduction Increased expression of IL-33 and its receptor ST2, encoded by the IL1RL1 gene, has been detected in the inflamed arteries of giant cell arteritis (GCA) patients. The aim of the present study was to investigate for the first time the potential influence of the IL33 and IL1RL1 loci on GCA predisposition. Methods A total of 1,363 biopsy-proven GCA patients and 3,908 healthy controls from four European cohorts (Spain, Italy, Germany and Norway) were combined in a meta-analysis. Six genetic variants: rs3939286, rs7025417 and rs7044343, within the IL33 gene, and rs2058660, rs2310173 and rs13015714, within the IL1RL1 gene, previously associated with immune-related diseases, were genotyped using predesigned TaqMan assays. Results A consistent association between the rs7025417 polymorphism and GCA was evident in the overall meta-analysis, under both allele (PMH = 0.041, OR = 0.88, CI 95% 0.78-0.99) and recessive (PMH = 3.40E-03, OR = 0.53, CI 95% 0.35-0.80) models. No statistically significant differences between allele or genotype frequencies for the other IL33 and IL1RL1 genetic variants were detected in this pooled analysis. Conclusions Our results clearly evidenced the implication of the IL33 rs7025417 polymorphism in the genetic network underlying GCA.
publishDate 2014
dc.date.none.fl_str_mv 2014
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/118222
url https://hdl.handle.net/2445/118222
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0113476
PLoS One, 2014, vol. 9, num. 11, p. e113476
https://doi.org/10.1371/journal.pone.0113476
dc.rights.none.fl_str_mv cc-by (c) Márquez, Ana et al., 2014
http://creativecommons.org/licenses/by/3.0/es
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc-by (c) Márquez, Ana et al., 2014
http://creativecommons.org/licenses/by/3.0/es
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Public Library of Science (PLoS)
publisher.none.fl_str_mv Public Library of Science (PLoS)
dc.source.none.fl_str_mv Articles publicats en revistes (Medicina)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869408598573973504
score 15,300719